For decades, the lozenge sat in a quiet corner of the pharmacy shelf: trusty, familiar, and almost entirely associated with sore throats and winter coughs. Medilab Healthcare Pvt Ltd has other plans. The Pune-based manufacturer, already home to one of India’s most extensive lozenge portfolios, is now pushing the category into territory it has never occupied before: women’s health, sports nutrition, heart wellness, stress relief, and preventive care. The result is something the Indian healthcare market has not quite seen yet, a lozenge that works for your immune system, your fitness goals, or your cardiovascular health, not just the scratch at the back of your throat.
A New Category, Born in an Indian Facility
Medilab Healthcare’s flagship announcement centres on what it is calling India’s first wellness-focused lozenge range. While the global nutraceutical industry has long experimented with lozenge-based delivery systems, the domestic market has remained largely untouched in this regard. Medilab is changing that with a portfolio of over 250 formulations! A number that reflects not just scale, but a deliberate, research-backed effort to make lozenges a meaningful wellness tool.
The new range spans nine distinct health categories. Women’s Health Lozenges are designed to address nutritional needs specific to women, while Sports Nutrition Lozenges offer support for athletes focused on performance, recovery, and hydration. Immunity Support Lozenges come enriched with a combination of vitamins, minerals, and herbal ingredients. Digestive Wellness and Energy and Vitality variants cater to everyday health concerns. Herbal Wellness Lozenges draw on Ayurvedic ingredients refined through modern scientific formulation. Heart Wellness Lozenges address cardiovascular support, Kids Wellness variants make health supplements accessible and enjoyable for children, and Stress Relief and Relaxation Lozenges round out the range with a focus on mental well-being.
Each of these is not a rough concept waiting for its moment. They are production-ready formulations developed through Medilab’s in-house R&D team, manufactured under internationally certified conditions, and positioned to serve both domestic consumers and global B2B partners.
The Science Behind the Simplicity
The delivery mechanism: slow dissolution in the mouth allows for faster absorption of certain nutrients compared to conventional tablets or capsules. For some ingredients, particularly those targeting throat health, immunity, or quick-release energy, the lozenge format offers a genuine clinical advantage. Medilab’s formulation team has built the company’s entire product philosophy around this insight.
The company’s in-house Research and Development Centre functions as the backbone of its innovation pipeline. Scientists here work at the intersection of Ayurvedic knowledge and modern pharmacognosy, identifying ingredients with established traditional use, validating them through scientific research, and integrating them into formulations that meet contemporary quality benchmarks. The result is a product line that carries the credibility of both worlds.
This is not simply a marketing claim. Medilab’s manufacturing facility holds ISO, GMP, HALAL, and HACCP certifications; a combination that reflects compliance not just with Indian standards but with the regulatory expectations of export markets across Africa, the Middle East, Southeast Asia, Europe, and North America. Every batch that leaves the facility carries documentation that can withstand international scrutiny.
250 Formulations and Counting
Building a portfolio of 250 unique lozenge formulations requires sustained investment in R&D, a deep understanding of consumer health needs across multiple categories, and the manufacturing agility to produce very different products on the same lines without compromising quality or consistency. Medilab has done this across segments that include daily wellness, immunity, throat care, digestive health, women’s health, sports nutrition, heart care, herbal wellness, and speciality healthcare.
For pharmaceutical companies, nutraceutical brands, and private-label entrepreneurs looking to enter or expand within the lozenge segment, this breadth translates directly into commercial opportunity. A brand that wants to launch an immunity lozenge, a women’s wellness variant, and a sports nutrition product under a single label no longer needs three separate manufacturing partners. Medilab can manage the entire product range from a single facility, ensuring consistency in quality and reducing logistical complexity for the client.
Built for Business Partners
Medilab’s growth model is not purely consumer-facing. A significant part of the company’s strategy involves serving pharmaceutical companies, wellness brands, and B2B distributors through contract manufacturing and private-label services. The company provides end-to-end support, from product development and formulation customisation to manufacturing, packaging, and regulatory documentation.
This is particularly relevant for international partners who want to enter the Ayurvedic and herbal supplement category but lack the manufacturing infrastructure or formulation expertise to do so independently. Medilab’s certified facility and its experience across a wide product range make it a reliable back-end partner for global healthcare brands looking to tap into the growing consumer appetite for natural, science-backed wellness products.
The company’s competitive philosophy is worth noting here. Rather than measuring itself against rival manufacturers, Medilab benchmarks itself against its own previous performance. It is a quiet but confident stance, one that tends to produce genuine innovation rather than reactive positioning.
Ayurveda, Scaled for the World
By embedding Ayurvedic ingredients within formulations that meet GMP and ISO standards, and by producing those formulations in a HALAL-certified facility, Medilab is making Indian herbal wellness genuinely exportable. The company is not asking global markets to take traditional medicine on faith. It is presenting Ayurvedic solutions in a format, certified, validated, consistently manufactured, that international buyers and regulators can engage with on familiar terms.
This approach is well-timed. Global consumer interest in natural health products has grown steadily over the past several years, accelerated in part by a broader shift toward preventive healthcare following the disruptions of the pandemic era. Consumers in Europe, North America, and the Middle East are actively seeking alternatives to synthetic supplements. Indian Ayurveda, delivered through a high-quality, internationally certified manufacturer, is positioned well to meet that demand.
What’s Next: A Facility Built for the Future
Medilab’s immediate future is anchored in a significant expansion of its manufacturing infrastructure. The company is developing an integrated facility that will extend its production capabilities well beyond lozenges. The new setup will include dedicated sections for Tablets, Capsules, Powders, Liquids, and Ointments, alongside its existing specialised lozenges unit, a Research and Development Centre, and comprehensive Quality Control and Quality Assurance laboratories.
Advanced Granulation Facilities are also part of the expansion plan, giving Medilab the ability to produce complex formulations with tighter particle control and improved bioavailability. The facility is being built to international regulatory standards, ensuring it is ready for the export markets the company is actively targeting.
This investment is not incidental. It signals Medilab’s intention to move from being a strong domestic player in the lozenge segment to becoming a comprehensive Ayurvedic, herbal, and nutraceutical manufacturing partner for global healthcare brands. The expanded facility will increase production capacity, shorten lead times for contract manufacturing clients, and provide the regulatory infrastructure needed to serve regulated markets in Europe and North America.
Wellness in Every Lozenge
There is something quietly radical about Medilab’s approach to its category. The lozenge has spent decades as a secondary healthcare product, something you buy when you are already unwell, as an accompaniment to rest and fluids. Medilab is proposing a different relationship between the consumer and the format: one where the lozenge becomes part of a daily wellness routine rather than a response to illness.
Sports nutrition consumers already accept the idea of consuming specific nutrients before, during, or after exercise. Women in the preventive health space are comfortable with targeted supplementation for hormonal balance and bone health. Heart health consumers regularly take omega-3 and CoQ10 formulations. Medilab’s contribution is to make all of these available in a format that is simpler, more portable, and more enjoyable to consume than a capsule or a powder.
The Kids Wellness Lozenges, in particular, address one of the most persistent challenges in paediatric supplementation, palatability. Children who refuse tablets or gag on syrups are often far more willing to consume a well-formulated lozenge. For parents navigating immunity support or digestive health for their children, this is not a small thing.
Medilab Healthcare is not simply launching new products. It is making an argument about what a lozenge can be and building the manufacturing, research, and commercial infrastructure to back that argument up. For consumers, that means a more convenient, more enjoyable path to daily wellness. For healthcare brands, pharmaceutical companies, and international distributors, it means a credible Indian manufacturing partner with the formulation depth, the certifications, and the global ambition to grow alongside them.
First in India. Ready for the world.
About Medilab Healthcare Pvt. Ltd.
Founded and headquartered in Pune, Maharashtra, Medilab Healthcare Pvt. Ltd. is a GMP- and ISO-certified pharmaceutical and Ayurvedic manufacturer specialising in B2B supply, private label manufacturing, and contract production. Its flagship consumer product, Medisils Ayurvedic Throat Lozenges, is distributed across 18 Indian states. The company’s new Cosmetics Manufacturing Division expands its service offering into personal care OEM and export-oriented production.
For more information: www.medilabhealthcare.com | info@medilabhealthcare.com
Disclaimer :
This article is a work of original content created for public relations and informational purposes only. It may be published across multiple digital platforms with the full knowledge and consent of the author/publisher. All images, logos, and referenced names are the property of their respective owners and used here solely for illustrative or informational purposes. Unauthorized reproduction, distribution, or modification of this article without prior written permission from the original publisher is strictly prohibited. Any resemblance to other content is purely coincidental or used under fair use policy with proper attribution.
